BlueWhale Bio
BlueWhale Bio is a startup headquartered in Philadelphia, United States, founded in 2022. It has raised at least $5.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
BlueWhale Bio has raised at least $5.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
BlueWhale Bio sits inside the Philadelphia region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Philadelphia
- Alveus Therapeutics
- Daymark Health
- FORE US Bio
- Interius BioTherapeutics
- Metabolics Pharma
- OnCall Health
- Peptaris
- QualiaOS
- Ritten
- Tolerance Bio
- Twenty30 Health
Related
- Innovation profile of Philadelphia
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does BlueWhale Bio do?
BlueWhale Bio is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has BlueWhale Bio raised?
At least $5.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is BlueWhale Bio based?
BlueWhale Bio is headquartered in Philadelphia, United States.
When was BlueWhale Bio founded?
BlueWhale Bio was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.